ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Monday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Down 15.5 %

NASDAQ OBSV opened at $0.10 on Monday. The firm has a 50-day simple moving average of $0.01. ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14. The company has a market cap of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.